Uwe Andag, Project Leader Metabolic Disease at Evotec

Uwe Andag

Project Leader Metabolic Disease at Evotec | Göttingen, Lower Saxony, Germany

Profile last verified October 2026
Pharmaceuticals Verified Profile Göttingen, Lower Saxony, Germany University of Hannover
Verified

Work Email

***@evotec.com

Last verified May 2026

Personal Email

***@freenet.de

Personal • High Confidence

Phone Number

+49*****

Germany • Mobile

Free account · No credit card · 5 profiles/month

Uwe Andag Socials
Uwe Andag Work Experience

Project Leader Metabolic Disease at Evotec in November 2010 - Present

VP Diabetic Complications at Evotec in April 2013 - Present

SVP Diabetic Complications at Evotec in April 2017 - Present

See more See less

SVP Head of Metabolic Disease at Evotec in August 2019 - Present

EVP Head of Therapeutic Areas at Evotec in July 2025 - Present

EVP Head of Metabolic & Renal Diseases at Evotec in April 2020 - July 2025

R&D Scientist at Sartorius Stedim Biotech GmbH in July 2006 - October 2010

Manager In Vitro Pharmacology at Develogen in November 2002 - July 2006

PhD student at MPIBPC in January 2000 - December 2003

Uwe Andag Education

University of Hannover, Dr. rer. nat, November 1994 to November 2026

The University of Göttingen, Diploma, November 1999

Uwe Andag Skills
Biochemistry Protein Chemistry Cell Based Assays In Vitro Pharmacology Cell Biology Lifesciences Assay Development ELISA Cell Drug Discovery Biotechnology
About Uwe Andag’s Current Company
Evotec

Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients. Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing. We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI. We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.

Discover more about Evotec
Uwe Andag’s Colleagues
Christian Wojczewski

Christian Wojczewski

Hamburg, Hamburg, Germany

Experienced CEO and advisor of Healthcare companies

CEO at Evotec
(July 2024 – Present)

Jakob Freitag

Jakob Freitag

Berlin, Berlin, Germany

Integration First

Owner at evolution|one
(October 1999 – Present)

Giuseppina Claps

Giuseppina Claps

Toulouse, Occitanie, France

Research Scientist - Team Leader - preclinical in vivo pharmacology

Research Scientist - Team Leader - preclinical in vivo pharmacology at Evotec
(February 2021 – Present)

Francois Autelitano

Francois Autelitano

Toulouse, Occitanie, France

Vice-President, Head of Translational Proteomics & Metabolomics - Modality Lead for Covalent Drugs - Evotec France

Vice-President, Head of Translational Proteomics & Metabolomics at Evotec
(April 2020 – Present)

Gillesolivier Gratien

Gillesolivier Gratien

Toulouse, Occitanie, France

Research Scientist | Team Leader in Medicinal Chemistry at Evotec

Research Scientist | Team Leader in Synthetic and Medicinal Chemistry at Evotec
(November 2023 – Present)

Justyna Wojnopicon

Justyna Wojnopicon

Toulouse, Occitanie, France

Drug Discovery Project Leader at Evotec/ Medicinal Chemist

Integrated Drug Discovery Project Leader, GL Medicinal Chemistry at Evotec
(August 2022 – Present)

Search similar profiles
Frequently asked questions about Uwe Andag

What is Uwe Andag email address?

Email Uwe Andag at [email protected], [email protected] and [email protected]. This email is the most updated Uwe Andag's email found in 2026.

What is Uwe Andag phone number?

Uwe Andag phone number is +4915114737419.

How to contact Uwe Andag?

To contact Uwe Andag send an email to [email protected], [email protected] or [email protected]. If you want to call Uwe Andag try calling on +4915114737419. (updated on November 06, 2025)

What company does Uwe Andag work for?

Uwe Andag works for Evotec.

What is Uwe Andag's role at Evotec?

Uwe Andag is Project Leader Metabolic Disease

What industry does Uwe Andag work in?

Uwe Andag works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free